Yi Lyu Selected Research

niazirin

6/2021

Niazirin from Moringa oleifera Lam. attenuates high glucose-induced oxidative stress through PKCζ/Nox4 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi Lyu Research Topics

Disease

6	Ischemic Stroke 12/2019 - 01/2017
3	Inflammation (Inflammations) 01/2021 - 01/2017
3	Neoplasms (Cancer) 03/2020 - 02/2016
3	Stroke (Strokes) 01/2018 - 01/2018
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2015 - 08/2014
2	Hypoxia (Hypoxemia) 05/2022 - 02/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 08/2020
2	Necrosis 01/2022 - 12/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 06/2021 - 01/2021
2	Ischemia 05/2020 - 01/2019
2	Hypertension (High Blood Pressure) 11/2018 - 01/2017
1	Starvation 05/2022
1	Phlebitis 04/2022
1	Deglutition Disorders (Dysphagia) 01/2022
1	Brain Stem Infarctions (Weber Syndrome) 01/2022
1	Infections 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Liver Failure 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2021
1	Hyperglycemia 06/2021
1	Atherosclerosis 06/2021
1	Diabetes Complications 06/2021
1	Hypertrophy 01/2021
1	COVID-19 01/2021
1	Fever (Fevers) 01/2021
1	Left Ventricular Dysfunction 01/2021
1	Memory Disorders (Memory Loss) 09/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2020
1	Neoplasm Metastasis (Metastasis) 05/2020
1	Liver Diseases (Liver Disease) 05/2020
1	Carcinoma (Carcinomatosis) 05/2020
1	Sepsis (Septicemia) 04/2020
1	Disease Resistance 01/2020
1	Chronic Renal Insufficiency 10/2019
1	Sarcoma (Soft Tissue Sarcoma) 07/2019
1	Adenocarcinoma of Lung 01/2019
1	Postoperative Cognitive Complications 01/2019
1	Aneurysm (Aneurysms) 01/2019
1	Aortic Dissection 01/2019

Drug/Important Bio-Agent (IBA)

6	Kallikreins (Kallikrein)IBA 12/2019 - 01/2017
3	Carotenoids (Carotene)IBA 01/2021 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 09/2020 - 08/2014
2	AntibodiesIBA 05/2022 - 01/2018
2	FluoridesIBA 02/2022 - 10/2019
2	AntioxidantsIBA 06/2021 - 01/2021
2	OxygenasesIBA 01/2021 - 10/2020
2	Dexmedetomidine FDA Link 01/2019 - 12/2016
1	SulfitesIBA 05/2022
1	ArsenicIBA 02/2022
1	Dioctyl Sulfosuccinic Acid (DOSS)IBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	CateninsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2021
1	niazirinIBA 06/2021
1	jinhua qinggan granulesIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	TEMPOIBA 01/2021
1	CytokinesIBA 01/2021
1	astaxanthine (astaxanthin)IBA 10/2020
1	Peptides (Polypeptides)IBA 08/2020
1	ParaffinIBA 03/2020
1	Membrane LipidsIBA 01/2020
1	EdaravoneIBA 12/2019
1	3-n-butylphthalide (butylphthalide)IBA 12/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 10/2019
1	arseniteIBA 10/2019
1	Drinking WaterIBA 10/2019
1	Syk KinaseIBA 07/2019
1	O-(6)-methylguanineIBA 07/2019
1	MethyltransferasesIBA 07/2019
1	Vinyl Chloride (Chloroethylene)IBA 07/2019
1	ral Guanine Nucleotide Exchange FactorIBA 07/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2019
1	DNA (Deoxyribonucleic Acid)IBA 07/2019
1	CarbohydratesIBA 01/2019
1	urinastatin (MR 20)IBA 01/2019
1	tissue polypeptide specific antigenIBA 01/2019
1	Xiexin decoctionIBA 01/2019
1	sanhuangIBA 01/2019
1	Carcinoembryonic AntigenIBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2019
1	Tissue Polypeptide AntigenIBA 01/2019

Therapy/Procedure

6	Therapeutics 04/2022 - 02/2016
3	Aftercare (After-Treatment) 01/2018 - 01/2018
3	Islets of Langerhans Transplantation 10/2015 - 08/2014
1	Catheters 04/2022
1	Transcranial Direct Current Stimulation 01/2022
1	Liver Transplantation 10/2021
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 02/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021
1	Percutaneous Coronary Intervention 01/2021
1	Continuous Positive Airway Pressure 06/2020
1	Hepatectomy 05/2020
1	Hemofiltration 04/2020
1	Continuous Renal Replacement Therapy 04/2020
1	Extracorporeal Circulation 01/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2019